ST Humanwell (600079.SH): Midazolam Nasal Spray Receives Drug Clinical Trial Approval Notice

Zhitong Finance APP news, ST Renfu (600079.SH) announced that its controlling subsidiary Yichang Renfu Pharmaceutical Co., Ltd. (referred to as "Yichang Renfu", in which the company holds 80% equity) recently received the "Drug Clinical Trial Approval Notice" for Midazolam Nasal Spray approved and issued by the National Medical Products Administration.